Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

BioTrove’s RapidFire business unit to become independent subsidiary
December 2009
SHARING OPTIONS:

WOBURN, Mass.—BioTrove Inc. announced Nov. 10 that it is forming a wholly owned subsidiary named BIOCIUS Life Sciences to hold the assets of the RapidFire business unit. Upon completion of Life Technologies' proposed acquisition of BioTrove, BIOCIUS Life Sciences will be spun-out as an independent operating company and continue to offer contract research services for lead discovery and CYP Inhibition on the RapidFire platform as well as RapidFire instrumentation. BioTrove said RapidFire mass spectrometry is used by 13 of the top 15 pharmaceutical companies to decrease the bottlenecks that occur during drug discovery. Financial terms were not disclosed.
 
    
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.